Alpine Global Management’s Ibere Pharmaceuticals Warrants IBER.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-11,625
Closed – – 555
2022
Q4
$0 Sell
11,625
-50,000
-81% -$1.58K ﹤0.01% 690
2022
Q3
$5K Buy
61,625
+200
+0.3% +$21 ﹤0.01% 265
2022
Q2
$5K Buy
+61,425
New +$10.6K ﹤0.01% 385

Other funds holding IBER.WS

Alpine Global Management's IBER.WS Position: Q1 2023 in Review

Alpine Global Management sold out of Ibere Pharmaceuticals Warrants (IBER.WS) in Q1 2023, closing a stake of 11,625 shares.

Alpine Global Management first reported a position in IBER.WS in Q2 2022 and held it in 3 quarters. The position peaked at $5K in Q3 2022. 1 fund tracked by Wall St. Rank holds IBER.WS as of Q1 2023.

  • Alpine Global Management reported no remaining Ibere Pharmaceuticals Warrants position as of Q1 2023 after selling out during the quarter.
  • Alpine Global Management sold 11,625 Ibere Pharmaceuticals Warrants shares in Q1 2023.
  • Alpine Global Management first reported a position in Ibere Pharmaceuticals Warrants in Q2 2022 and held it in 3 quarters.
  • Alpine Global Management's Ibere Pharmaceuticals Warrants position peaked at $5K in Q3 2022.
  • 1 fund tracked by Wall St. Rank held Ibere Pharmaceuticals Warrants as of Q1 2023.

Based on Alpine Global Management's 13F filing for Q1 2023, filed 15 May 2023.